Haemonetics | HAE - Ebitda

Stock Price
64.86
Daily Change
-0.92 -1.40%
Monthly
-21.01%
Yearly
-5.89%
Q1 Forecast
64.61

Haemonetics reported $115.53M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Avanos Medical USD -63.9M 85.5M Jun/2025
Baxter International USD 462M 137M Jun/2025
Becton, Dickinson and Co. USD 2.15B 674M Sep/2025
Boston Scientific USD 1.37B 9M Jun/2025
Cooper Companies USD 336.6M 14.8M Sep/2025
Fresenius EUR 850M 22M Sep/2025
Fresenius Medical Care EUR 931.26M 60.26M Sep/2025
Globus Medical USD 252.6M 43.92M Sep/2025
Haemonetics USD 115.53M 9.22M Sep/2025
Hologic USD 330.4M 16.6M Dec/2025
ICU Medical USD 100.31M 36.51M Jun/2025
Intuitive Surgical USD 919.7M 21M Sep/2025
Masimo USD 72M 42.6M Jun/2025
Medtronic USD 2.44B 139M Sep/2025
Merit Medical Systems USD 83.96M 10.65M Jun/2025
Neogen USD 48.75M 13.28M Sep/2025
Quidel USD 177.1M 70.3M Sep/2025
ResMed USD 547.48M 27.46M Dec/2025
STAAR Surgical USD 34.62M 49.56M Sep/2025
Steris USD 367.2M 13.42M Jun/2025
Stryker USD 1.67B 206M Sep/2025
Teleflex USD 207.62M 15.28M Jun/2025
Terumo JPY 66.76B 10.31B Sep/2025
Thermo Fisher Scientific USD 3.17B 335M Dec/2025
US Physical Therapy USD 23.86M 3.01M Sep/2025
Zimmer Biomet Holdings USD 575.7M 26.1M Jun/2025